Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study

Fertility and Sterility
W P DmowskiP Pepping

Abstract

The effectiveness of Buserelin (Hoechst-Roussel Pharmaceuticals, Inc., Somerville, NJ) (0.2 mg subcutaneously [SC] or 1.2 mg intranasally [IN] per day) and danazol (800 mg per day) in inducing ovarian suppression for the management of endometriosis was compared in a prospective randomized study. During 6 months of treatment, peripheral follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol concentrations were suppressed to a similar degree in both groups. Symptomatic improvement and laparoscopically assessed regression of endometriotic lesions also were comparable. After treatment, 8 of 18 infertile women treated with Buserelin and 5 of 8 treated with danazol conceived. General and hypoestrogenic side effects were similar in both groups, while androgenic and anabolic were more frequent with danazol. High density lipoprotein (HDL)-cholesterol increased in the Buserelin and decreased in the danazol group. The study indicates that at the dose tested, buserelin and danazol induce a similar degree of ovarian suppression resulting in a comparable clinical improvement and regression of endometriotic lesions.

Citations

Nov 1, 1993·British Journal of Obstetrics and Gynaecology·P VandekerckhoveT W Harada
Mar 1, 1994·British Journal of Obstetrics and Gynaecology·A PickersgillR G Farquharson
May 1, 1994·British Journal of Obstetrics and Gynaecology·M A Damario, J A Rock
Aug 23, 2000·Current Opinion in Obstetrics & Gynecology·K D Jones, C J Sutton
Aug 4, 2006·Clinical Obstetrics and Gynecology·Saeed AlborziMehrnoosh Alborzi
Apr 7, 2018·Reproductive Sciences·Ilona Kowalczyk-ZiebaSlawomir Wolczynski
Feb 15, 2019·Expert Opinion on Biological Therapy·Fabio BarraSimone Ferrero
Jun 1, 1991·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·K BiberogluA Yildiz
Sep 29, 2020·Expert Opinion on Drug Delivery·Simone GarzonSimone Ferrero
Aug 28, 1998·Current Opinion in Obstetrics & Gynecology·C Farquhar, C Sutton
Jul 28, 2001·The New England Journal of Medicine·D L Olive, E A Pritts
Jul 20, 2007·The Cochrane Database of Systematic Reviews·E HughesP Vandekerckhove
Sep 3, 2014·Human Reproduction Update·Nicolas BourdelMichel Canis
Jul 6, 2018·Expert Opinion on Pharmacotherapy·Simone FerreroFabio Barra
Mar 27, 2001·Journal of Women's Health & Gender-based Medicine·C A Winkel, A R Scialli
Nov 2, 2006·The Tohoku Journal of Experimental Medicine·Yuka OzawaIchiro Tsuji
Jul 1, 2020·Expert Opinion on Drug Metabolism & Toxicology·Luigi Della CortePierluigi Giampaolino
Sep 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M A Damario, J A Rock
Apr 13, 2002·Annals of the New York Academy of Sciences·David L Olive, Elizabeth A Pritts
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Julie BrownRoger J Hart
Jul 20, 2007·The Cochrane Database of Systematic Reviews·A PrenticeS K Smith
Jun 28, 2018·Drugs·Simone FerreroUmberto Leone Roberti Maggiore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.